Bio-Thera Solutions, Ltd. (SHA:688177)
China
· Delayed Price · Currency is CNY 22.44
-0.18 (-0.80%)
At close: Mar 9, 2026
Bio-Thera Solutions Revenue
In the year 2025, Bio-Thera Solutions had annual revenue of 933.69M CNY with 25.64% growth. Bio-Thera Solutions had revenue of 250.10M in the quarter ending December 31, 2025, with 54.64% growth.
Revenue
933.69M
Revenue Growth
+25.64%
P/S Ratio
9.95
Revenue / Employee
746.35K
Employees
1,266
Market Cap
9.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 933.69M | 190.52M | 25.64% |
| Dec 31, 2024 | 743.17M | 38.37M | 5.44% |
| Dec 31, 2023 | 704.79M | 249.66M | 54.86% |
| Dec 31, 2022 | 455.13M | -381.45M | -45.60% |
| Dec 31, 2021 | 836.58M | 653.72M | 357.49% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chongqing Genrix Biopharmaceutical | 230.72M |
| Shanghai Medicilon | 1.08B |
| Chengdu Easton Biopharmaceuticals | 1.33B |
| Sino Biological,Inc. | 660.17M |
| Daan Gene | 765.48M |
| Aurisco Pharmaceutical | 1.62B |
| Liaoning Chengda Biotechnology | 1.39B |
| Youcare Pharmaceutical Group | 2.45B |